Cardiac phenotype in adolescents and young adults with long-chain 3-hydroxyacyl CoA dehydrogenase (LCHAD) deficiency

Gabriela Elizondo,Ajesh Saini,Cesar Gonzalez de Alba,Ashley Gregor,Cary O. Harding,Melanie B. Gillingham,Jeffrey M. Vinocur

DOI: https://doi.org/10.1016/j.gim.2024.101123

IF: 8.864

2024-03-18

Genetics in Medicine

Abstract:Background Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD) is a rare fatty acid oxidation disorder characterized by recurrent episodes of metabolic decompensation and rhabdomyolysis as well as retinopathy, peripheral neuropathy, and cardiac involvement such as infantile dilated cardiomyopathy. As LCHADD patients are surviving longer, we sought to characterize LCHADD-associated major cardiac involvement in adolescence and young adulthood. Methods A retrospective cohort of 16 adolescent and young adult participants with LCHADD was reviewed for cardiac phenotype. Results Major cardiac involvement occurred in 9 of 16 participants, including sudden death, out-of-hospital cardiac arrest, acute cardiac decompensations with heart failure and/or in-hospital cardiac arrest, end-stage dilated cardiomyopathy, and moderate restrictive cardiomyopathy. Sudden cardiac arrest was more common in males and those with a history of infant cardiomyopathy. Conclusion The cardiac manifestations of LCHADD in adolescence and early adulthood are complex and distinct from the phenotype seen in infancy. Life-threatening arrhythmia occurs at substantial rates in LCHADD, often in the absence of metabolic decompensation or rhabdomyolysis . The potential risk factors identified here – male gender and history of infant cardiomyopathy -may hint at strategies for risk stratification and possibly prevention of these events.

genetics & heredity